Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 71335-1897

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 71335-1897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Image 01)

Chemical structure of diltiazem hydrochloride showing the molecular arrangement including benzene rings, sulfur, nitrogen, oxygen atoms, and the hydrochloride (HCl) component.*

FDA Label Image

Image (Image 02)

A data table presenting adverse reactions from placebo-controlled angina and hypertension trials comparing diltiazem hydrochloride extended-release capsules (n=607) with placebo (n=301). The table lists rates of headache, dizziness, bradycardia, first degree AV block, edema, and asthenia with corresponding percentages for each group.*

FDA Label Image

Label (Lbl713351897)

Label for diltiazem hydrochloride extended release 360 mg capsule by Bryant Ranch Prepack. The label notes the product is a blue capsule marked N369;360 and provides storage instructions to keep at room temperature (20°-25°C). It displays the NDC 71335-1897-71 and includes a barcode, lot number, and safety warning to keep all drugs out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.